Saturday, October 3, 2015

Opioid Use Trajectories, Injection Drug Use and HCV Risk among Young Adult Immigrants from the Former Soviet Union Living in New York City

Available evidence suggests that young former Soviet Union immigrants in New York City have high rates of non-medical prescription opioid and heroin use, drug injection and injection-related risk behavior, making them vulnerable to hepatitis C virus (HCV)/human immunodeficiency virus (HIV) infection, overdose and associated harms. This group has been the focus of little research, however. This paper presents quantitative and qualitative data from 80 former Soviet immigrants (ages 18–29) to characterize their opioid use trajectories, injection risk behavior, HCV/HIV testing histories and self-reported HCV/HIV serostatus, and provides clinically meaningful data to inform tailored education, prevention and harm reduction interventions.

Table 2

Participants’ Opioid Use Characteristics
Characteristic (n=80; 40 in drug treatment, 40 not in drug treatment)
Age at 1st Opioid Use (M, Range, SD)17.75, 12–27, 3.33
First opioid used % (n)
  Heroin15+ (12)
  Rx opioid85 (68)
    Oxycodone (immediate-release)55 (44)
    OxyContin14 (11)
    Hydrocodone11 (9)
    Other Rx opioid5 (4)
ROA at 1st Opioid Use % (n)
  Oral56 (45)
  Intranasal34 (27)
  Smoking6 (5)
  Injection3 (2)
  Transdermal1 (1)
Age at 1st Regular Opioid Use (M, Range, SD)18.96, 12–28, 3.18
Ever Used Heroin % (n)79 (63)
Age at 1st Heroin Use (M, Range, SD)19.38, 12–28, 3.18
Primary Opioid (Current) % (n)
  Heroin53 (42)
  Methadone4 (3)
  Buprenorphine3 (2)
  Other Rx opioid15 (12)
  Not currently using (in drug treatment)26 (21)
Ever Injected % (n)76 (61)
Age at 1st Injection (M, Range, SD)20.43, 13–27, 3.25
Duration Regular Injection (months) (M, Range, SD)26.33, .5–120, 29.62
Primary ROA (Current) % (n)
  Oral13 (10)
  Intranasal18 (14)
  Smoking8 (6)
  Injection36 (29)
  Not currently using (in drug treatment)26 (21)
+Percentages may not add up to 100 due to rounding

Table 3

Past 12 Months Syringe Sources, Injection-related Risk Behavior and Level of Concern about HCV
Behavior (n=48 Participants Reporting Past 12 Months IDU)
Syringe Sources % (n)
  Pharmacy/drugstore73 (35)+
  Friend, relative or sex partner40 (19)
  Syringe exchange program40 (19)
Number of People Shared Syringes with (Receptive Sharing) % (n)
  067 (32)
  127 (13)
  26 (3)
Number of People Shared Other Injection Equipment with (Receptive Sharing) % (n)
  054* (26)
  127 (13)
  28 (4)
  3 or more10 (5)
Frequency of Receptive Syringe Sharing % (n)
  Never67 (32)
  Rarely27 (13)
  About half the time4 (2)
  Most of the time2 (1)
  Always0
Frequency of Receptive Sharing of Cookers % (n)
  Never58 (28)
  Rarely21 (10)
  About half the time15 (7)
  Most of the time4 (2)
  Always2 (1)
Frequency of Receptive Sharing of Cottons % (n)
  Never69 (33)
  Rarely19 (9)
  About half the time6 (3)
  Most of the time4 (2)
  Always2 (1)
Frequency of Receptive Sharing of Water or Water Containers % (n)
  Never60 (29)
  Rarely21 (10)
  About half the time10 (5)
  Most of the time4 (2)
  Always4 (2)
Level of Concern about Future Exposure to HCV % (n)
  Not at all worried40 (19)
  Slightly worried29 (14)
  Moderately worried6 (3)
  Considerably worried8 (4)
  Extremely worried15 (7)
+For this item only, numbers total >48 because multiple responses were allowed.
*Percentages may be <100 or due to rounding.

Full article at: http://ht.ly/SXXDW 

By: Honoria Guarino, Ph.D.,1 Lisa A. Marsch, Ph.D.,2 Sherry Deren, Ph.D.,3 Shulamith L.A. Straussner, Ph.D., L.C.S.W.,4and Anastasia Teper, M.A.1
1National Development and Research Institutes, Inc., New York, NY
2Dartmouth Psychiatric Research Center, Department of Psychiatry, Dartmouth College, Hanover, NH
3Center for Drug Use and HIV Research, New York University College of Nursing, New York, NY
4Silver School of Social Work, New York University, New York, NY 


No comments:

Post a Comment